Vascular Disease Management
INSIGHT INTO DIAGNOSIS AND TREATMENT OF VASCULAR DISEASE
MANAGEMENT
Thursday, May 15, 2008

SEARCH ARTICLES



Home | About
Current Issue
Archives
Subscribe
Board Members
Search Article Archives
Editor's Update
Events & Symposia
Industry News | Enews
Discussion Forum
Classifieds
Letter to the Editor
Comments/Suggestions
Editorial/Production
Author Information
Submit a Manuscript
Review a Manuscript
Order Article Reprints
Advertising
Advertising Specs
Online/Web Production

Featured Article

Ask the Expert: New Collaborative Multi-Societal Credentialing Guidelines for Carotid Artery Stenting
Feature:
Ask the Expert: New Collaborative Multi-Societal Credentialing Guidelines for Carotid Artery Stenting

- Christopher U. Cates, MD, FACC, FSCAI

Dr. Cates’ expertise is in interventional techniques for the treatment of coronary artery and vascular disease. He is recognized as a national leader in cardiology, especially in the area of managed care, and led the team that performed the first carotid artery stent procedure in Georgia in 1995. Since then, Dr. Cates has performed hundreds of carotid artery stent procedures and represented the ACC in writing the CPT code for carotid stenting and subsequent CPT approval for the carotid stent code. He is the Director of SCAI’s core curriculum course in carotid stenting.


Dr. Cates, you’ve been involved in helping the cardiology and vascular surgery societies develop credentialing guidelines for carotid artery stenting (CAS). How did these medical societies come together?


The societies felt it was important to take a role in helping define credentialing guidelines for CAS. Because this new procedure involves different anatomy and complications and because multiple specialists will be performing the procedure, a consistent set of guidelines will help to ensure the best patient care. So, the Society for Cardiovascular Angiography and Interventions (SCAI), the Society of Vascular Surgery (SVS), the Society for Vascular Medicine and Biology (SVMB) and
the American College of Cardiology (ACC) came together to develop recommendations that clearly define training and credentialing guidelines for physicians on the pathway to CAS.

What were the major considerations in developing the guidelines?

CAS is a high-risk, high-visibility procedure which is technically challenging and will be performed by physicians from multiple specialties. The societies sought to achieve consensus on guidelines for minimum numbers of cerebral angiography and CAS procedures required to achieve competency. The guidelines also address how physician operator competency should be measured in an ongoing fashion and define the minimum industry standards for device certification, including the use of simulation.

What do the guidelines cover?
The topics include general principles for training in carotid artery intervention; cognitive, technical and clinical skills requirements; industry-sponsored device certification; the use of proficiency-based simulation; tracking of individual physicians’ outcomes; minimum facility and equipment standards; and recommendations for outcomes measurement and quality assurance.

Could you give some specifics from the guidelines? Are there numbers of procedures that you’re recommending?
The guidelines require that 30 supervised carotid angiograms should be performed prior
to independent operator performance, with 15 cases performed as the primary operator. Once the angiogram criteria is met, then a minimum of 25 CAS procedures should be performed in a supervised setting prior to independent operator performance, with 13 CAS procedures as the primary operator.
Included in the guidelines is a provision that allows for some of the carotid angiogram and CAS cases to be in the form of simulation training performed in a metric-based program to meet the recommendations. The guidelines also set minimum standards for industry-sponsored device training, including online didactic
cognitive training, metric-based simulation training to proficiency, and proctoring.

What about monitoring physician performance in the CAS procedure?

We’re now working with the Centers for Medicare and Medicaid (CMS) to help determine how to monitor physician performance in an ongoing fashion after beginning CAS. The guidelines contain very important recommendations for tracking individual physicians’ and hospitals’ outcomes—this is very important. The societies proposed to CMS the creation of a mandatory reporting system that includes a national, independent, multi-societal database that will ultimately tie competency to clinical outcomes. The requirement for data collection in this database could also potentially be tied to future reimbursement for CAS.

Where can physicians and hospitals get the full set of guidelines?

The full set of guidelines has been published in the Journal of the American College of Cardiology (JACC), the Journal of Vascular Surgery (JVS), Catheterization and Cardiovascular Interventions (CCI), and the Journal of SCAI. They are also posted on the ACC and SCAI Web sites (www.acc.org
and www.scai.org, respectively).

What impact do you expect the new guidelines to have on hospitals, physicians and patients?

These multi-societal guidelines will give credentialing criteria that can be adopted by hospitals and local medical groups as a minimum and consistent standard of training and competency in carotid angiography and stenting. We all know that the brain is not a forgiving organ, and operators who are not adequately trained in CAS will probably experience significant negative outcomes.
The resulting patient morbidity and potential patient mortality could have a significant
negative impact on the adoption of this innovative procedure.

What is significant about the guidelines and the multi-societal process by which they were developed? Does this set the stage for future collaboration?

This may be one of the most important sets of guideline recommendations developed in interventional medicine because it will help to define consistent cross-specialty competency standards and get more physicians on the pathway to performing CAS. The process by which these guidelines were developed could well be a model for future collaborations. The societies had similarly joined together in order to get a CPT® code for CAS even before the procedure was FDA-approved. Certainly, effective societal collaboration is a lot of hard work but it is for the good of patients.


CPT is a registered trademark of the American Medical Association.

Sponsored by Boston Scientific Corporation.


Vascular Disease Management - ISSN: 1553-8036 - Volume 2 - Issue 3 - January 2005 - Pages: 10 - 10

VASCULAR TOPICS

Peripheral Angioplasty
Thoracic Stent Grafts
Renal Stenting
Vena Cava Filter
Hemodialysis Management
Computed Tomography
PFO Closure
SFA Stenting
Carotid Stenting
Vessel Closure
Angiography
Carotid Endarterectomy
Ultrasound

Critical Limb Ischemia
Superficial Femoral Artery
Embolization
Device Based Thrombectomy
Pharmacological Management
MRA
Mesenteric Artery Stenting
AAA Stent Grafts
Iliac Stenting
Thrombolysis Procedures Using Drug Therapy

SUPPLEMENTS

Superior Mesenteric Artery Revascularization and Retrograde Visualization
This clinical case update was supported through an unrestricted educational grant from Terumo Medical Corporation.

HMP Increased Cutaneous Sensibility in Patients with Diabetic Neuropathy Utilizing a Pharmacological Approach — Clinical Case Evidence

This clinical case update was supported through an unrestricted educational grant from Pamlab, LLC.

A New Biological Approachto Below-Knee Revascularization
A Review of the GORE PROPATEN Vascular Graft:
The Combination That Lasts

This special supplement was made possible through a grant from W. L. Gore

Combining Bilayered Living Cell Therapy with Minimally Invasive Vein Surgery:
Current Treatment Strategies for Venous Ulcers

This activity is supported by an educational grant from Organogenesis.

Pharmacotherapy in Peripheral Vascular Disease

Platelet Inhibition in Critical Limb Ischemia and Peripheral Vascular Interventions
DAVID E. ALLIE, MD

An Overview of Pharmacotherapy during Percutaneous Peripheral Interventions of Thrombotic Lesions
NICOLAS W. SHAMMAS, MD, MS, FACC


The Important Properties of Contrast Media: Focus on Viscosity

This special supplement was made possible through a grant from Guerbet LLC

RECENTLY ADDED

Anticoagulation Techniques for Peripheral Vascular Interventions

Archived Webcast





© 2008 HMP Communications | All Rights Reserved
83 General Warren Blvd., Suite 100, Malvern, PA 19355
Phone: 800.237.7285 610.560.0500 Fax: 610.560.0502
Privacy Policy